Engineered allogeneic T cells expressing an anti-CD19 STAR receptor bind CD19 and, via redirected TCR–CD3 signaling, directly kill target cells through perforin/granzyme-mediated cytolysis (and Fas–FasL apoptosis), MHC-independent.